Institutional Biosafety Committee for Clinical Gene Transfer (IBC-CGT)
The Dartmouth College Institutional Biosafety Committee for Clinical Gene Transfer (IBC-CGT) is a multidisciplinary committee charged with the review of clinical protocols involving gene transfer as defined in the NIH Guidelines For Research Involving Recombinant Or Synthetic Nucleic Acid Molecules.
About the Committee
The IBC-CGT reviews all human gene transfer experiments for compliance with the NIH Guidelines as specified in Section III-C: Experiments Covered by the NIH Guidelines, and approves those research projects that are found to conform to the NIH Guidelines.
For information on submitting your research to the IBC-CGT, see Submitting Clinical Gene Therapy Studies for Biosafety Review.
For information on IBC-CGT procedures, see the IBC-CGT Charter.